Sign Up to like & get
recommendations!
0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.19524
Abstract: This cohort study compares population-level temporal trends in survival before and after using immune checkpoint inhibitors and antibody-drug conjugates among patients with metastatic urothelial cancer.
read more here.
Keywords:
antibody drug;
urothelial cancer;
drug conjugates;
survival trends ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202001974
Abstract: Polypeptides are an important class of biodegradable polymers that have been widely used in drug delivery field. Owing to the controllable synthesis and robust side chain-functionalization ability, polypeptides have long been ideal candidates for conjugation…
read more here.
Keywords:
drug conjugates;
conjugates anticancer;
polypeptides drug;
drug ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26750
Abstract: The treatment landscape of multiple myeloma (MM) has evolved substantially, but it remains largely incurable so new treatment options are required. Antibody drug conjugates (ADCs) are an emerging therapeutic class used in Cancer to deliver…
read more here.
Keywords:
drug conjugates;
treatment;
multiple myeloma;
antibody drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Communications"
DOI: 10.1002/cac2.12387
Abstract: Antibody‐drug conjugates (ADCs) are a rapidly developing therapeutic approach in cancer treatment that has shown remarkable activity in breast cancer. Currently, there are two ADCs approved for the treatment of human epidermal growth factor receptor…
read more here.
Keywords:
drug conjugates;
breast cancer;
resistance;
antibody drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "ChemBioChem"
DOI: 10.1002/cbic.202400738
Abstract: An enhanced variant of the antimitotic toxin cryptophycin was conjugated to the anti‐Her2 monoclonal antibody (mAb) Trastuzumab upon Michael addition. Either antibodies with freed hinge‐region cysteines or THIOMAB formats with engineered cysteines in the mAbs…
read more here.
Keywords:
cryptophycin;
potency;
cell;
antibody drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "ChemMedChem"
DOI: 10.1002/cmdc.202500262
Abstract: Inspired by the “magic bullet” concept proposed over a century ago, antibody–drug conjugates (ADCs) are developed to enhance cancer therapy by linking monoclonal antibodies to a cytotoxic payload, aiming to overcome the limitations of conventional…
read more here.
Keywords:
linker design;
drug;
antibody drug;
linker ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34507
Abstract: Antibody–drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance.
read more here.
Keywords:
clinical trials;
drug conjugates;
related adverse;
treatment related ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2278
Abstract: Antibody–drug conjugates (ADCs) combine the specificity of an antibody with the cytotoxicity of a chemical agent. They represent a rapidly evolving area of oncology drug development and hold significant promise. There are currently nine ADCs…
read more here.
Keywords:
drug conjugates;
drug;
food drug;
antibody drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Electrophoresis"
DOI: 10.1002/elps.202200140
Abstract: Antibody–drug conjugates (ADCs) are a prospective class of new oncology therapeutics with the ability to deliver a cytotoxic drug to a targeted location. The concept appears simple, but ADCs are highly complex due to their…
read more here.
Keywords:
drug conjugates;
drug;
antibody drug;
conjugational heterogeneity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.27419
Abstract: Targeted delivery of therapeutic molecules into cancer cells is considered as a promising strategy to tackle cancer. Antibody–drug conjugates (ADCs), in which a monoclonal antibody (mAb) is conjugated to biologically active drugs through chemical linkers,…
read more here.
Keywords:
drug conjugates;
drug;
conjugates adcs;
cancer ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Pharmacology"
DOI: 10.1002/jcph.1720
Abstract: Antibody‐drug conjugates are important molecular entities in the treatment of cancer, with 8 antibody‐drug conjugates approved by the US Food and Drug Administration since 2000 and many more in early‐ and late‐stage clinical development. These…
read more here.
Keywords:
drug conjugates;
drug;
pharmacology;
antibody drug ... See more keywords